Health

Covid Variant JN.1 Now Accounts for Nearly Half of U.S. Cases

Covid Variant JN.1 Now Accounts for Nearly Half of U.S. Cases

As the holiday season winds down and Covid-19 cases start to pick up, a variant called JN.1 has now become the most common strain of the virus spreading across the United States.JN.1, which emerged from the variant BA.2.86 and was first detected in the United States in September, accounted for 44 percent of Covid cases nationwide by mid-December, up from about 7 percent in late November, according to data from the Centers for Disease Control and Prevention. To some extent, this jump is to be expected. “Variants take some time to get going,” said Dr. William Schaffner, an infectious disease…
Read More
Serious Medical Errors Rose After Private Equity Firms Bought Hospitals

Serious Medical Errors Rose After Private Equity Firms Bought Hospitals

The rate of serious medical complications increased in hospitals after they were purchased by private equity investment firms, according to a major study of the effects of such acquisitions on patient care in recent years.The study, published in JAMA on Tuesday, found that, in the three years after a private equity fund bought a hospital, adverse events including surgical infections and bed sores rose by 25 percent among Medicare patients when compared with similar hospitals that were not bought by such investors. The researchers reported a nearly 38 percent increase in central line infections, a dangerous kind of infection that…
Read More
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research

Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research

When Dr. Monica M. Bertagnolli moved into the director’s suite at the National Institutes of Health, she brought with her a single piece of art, a lithograph created by the granddaughter of a cancer patient she once treated. It depicts an abstract geometric female figure and the organs she lost to cancer. Its title: “We Are Not What You Have Taken: A Response to Cancer.”The image speaks to Dr. Bertagnolli, a cancer surgeon who previously led the National Cancer Institute and is a breast-cancer survivor herself.After being nominated by President Biden in the spring and winning Senate confirmation last month,…
Read More
Bristol Myers to Acquire the Drugmaker Karuna for  Billion

Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

Bristol Myers Squibb, the global pharmaceutical giant, said on Friday that it would acquire Karuna Therapeutics, which makes drugs to treat schizophrenia and Alzheimer’s, in an all-cash deal valued at $14 billion as it looks to strengthen its pipeline of neuroscience drugs.Bristol Myers said in a statement that it would pay $330 per share in cash, a premium of roughly 53 percent to Karuna’s share price on Thursday.An increasing prevalence of schizophrenia, driven in part by an aging population, has led to a push to make more drugs to treat it. The market for such therapies is estimated to grow…
Read More
Americans Are Signing Up for Obamacare in Record Numbers

Americans Are Signing Up for Obamacare in Record Numbers

Why It Matters: The Affordable Care Act is expanding its reach.Despite a recent warning from former President Donald J. Trump, the front-runner in the race for the 2024 Republican presidential nomination, that he was “seriously looking at alternatives” to the Affordable Care Act, the latest surge in marketplace enrollment is a testament to the law’s enduring power.Legislation passed earlier in the Covid-19 pandemic increased federal subsidies for people buying plans, lowering the costs for many Americans. The Biden administration also lengthened the sign-up period and increased advertising for the program and funding for so-called navigators who help people enroll.“More and…
Read More
New Hope — and an Old Hurdle — for a Terrible Disease With Terrible Treatments

New Hope — and an Old Hurdle — for a Terrible Disease With Terrible Treatments

Three years ago, Jesús Tilano went to a hospital in a thickly forested valley in Colombia with large open lesions on his nose, right arm and left hand. He was diagnosed with leishmaniasis, a parasitic disease that is spread in the bite of a female sand fly and which plagues poor people who work in fields or forests across developing countries.He was prescribed a drug that required three injections a day for 20 days, each one agonizingly painful. Mr. Tilano, 85, had to make repeated expensive bus trips to town to get them. Then his kidneys started to fail, which…
Read More